--- title: "Amesite Inc. 3Q 2026: Revenue $83.33K, EPS ($0.15) — 10-Q Summary" type: "News" locale: "en" url: "https://longbridge.com/en/news/286818214.md" description: "Amesite Inc. reported Q3 2026 revenue of $83.33K, a net loss of $678.06K, and diluted EPS of ($0.15), compared to $30.69K revenue and ($0.16) EPS in Q3 2025. Revenue growth for the nine months reached $285.7K, driven by a shift to healthcare markets and the launch of AI-driven NurseMagic™. The company focused on operational efficiency, reducing spending and shifting to monthly service contracts." datetime: "2026-05-18T20:51:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286818214.md) - [en](https://longbridge.com/en/news/286818214.md) - [zh-HK](https://longbridge.com/zh-HK/news/286818214.md) --- # Amesite Inc. 3Q 2026: Revenue $83.33K, EPS ($0.15) — 10-Q Summary Amesite Inc. reported third-quarter 2026 results showing revenue of $83.33K, a net loss of ($678.06K) and diluted loss per share of ($0.15), compared with revenue of $30.69K, a net loss of ($663.42K) and diluted loss per share of ($0.16) in the prior-year quarter. **Financial Highlights** Metric Current quarter Prior year quarter YoY change Revenue¹ $83.33K $30.69K 171.5% Net income² ($678.06K) ($663.42K) (2.2%) Diluted EPS³ ($0.15) ($0.16) 6.3% _¹ Reported as “Net Revenue”. ² Reported as “Net Loss”. ³ Reported as “diluted loss per share”._ **Business Highlights** - Revenue growth for the nine months reached $285.7K versus $54.7K a year earlier, indicating early commercial traction. - The company shifted go-to-market focus from academic customers to healthcare, launching its AI-driven NurseMagic™ product to target immediate market demand. - Product development concentrated on AI tools while reducing large cash-upfront deals to lower risk and cash burn. - Operational efficiency moves included reduced technology, marketing and G&A spending through headcount reductions and insourcing to lower cash burn. - Customer billing shifted toward ratable monthly service contracts, with modest receivables and deferred revenue balances reported. Original SEC Filing: Amesite Inc. \[ AMST \] - 10-Q - May. 18, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [AMST.US](https://longbridge.com/en/quote/AMST.US.md) - [IHF.US](https://longbridge.com/en/quote/IHF.US.md) - [XHS.US](https://longbridge.com/en/quote/XHS.US.md) ## Related News & Research - [Amesite Secures Largest Home Care NurseMagic Deployment](https://longbridge.com/en/news/286918906.md) - [UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP](https://longbridge.com/en/news/286878927.md) - [AI face is taking over — and driving plastic surgeons crazy](https://longbridge.com/en/news/286641783.md) - [Jack Antonoff tells people who are making AI art to 'drive right off that cliff'](https://longbridge.com/en/news/286592426.md) - [AI disruptor listed on CNBC 50 for third year in a row.](https://longbridge.com/en/news/286901079.md)